Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ad87c2f33a30df644248bdfea647f35 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-734 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-32 |
filingDate |
2008-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eda7368da7416e7804a69e2f9c601d0f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eac8b2675e74a25945ebdc8d8d872452 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b01058f4dbbf5f0ebd513278a3d80729 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ad22c29342fd72b03822ca2384b1bbe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5c1c82f9b7ce820044e0401c24ee725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11a5a6d6ffae3d4ab72b0d77186b27c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14168731f9d0e94f1889cc950bb10697 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c9c3c15e1549943cc547cf51248ad96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba3443d43473cf17b808eb72ae311a59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe79d8b81ce748c5b0548928999ed590 |
publicationDate |
2014-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20140066785-A |
titleOfInvention |
Anti-prolonged Type I glycosin-binding lipid antibodies, derivatives and uses thereof |
abstract |
The present invention relates to a human antibody that specifically binds to an extended I-chain chain glycosylation peptide and to the antigen-binding portion of the antibody. |
priorityDate |
2008-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |